IN2012DN00879A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00879A IN2012DN00879A IN879DEN2012A IN2012DN00879A IN 2012DN00879 A IN2012DN00879 A IN 2012DN00879A IN 879DEN2012 A IN879DEN2012 A IN 879DEN2012A IN 2012DN00879 A IN2012DN00879 A IN 2012DN00879A
- Authority
- IN
- India
- Prior art keywords
- prt8
- prt6
- prt7
- polypeptides
- involved
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL200202A IL200202A0 (en) | 2009-08-02 | 2009-08-02 | Novel proteins |
PCT/IL2010/000621 WO2011016026A2 (en) | 2009-08-02 | 2010-08-02 | Novel proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00879A true IN2012DN00879A (he) | 2015-07-10 |
Family
ID=42263570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN879DEN2012 IN2012DN00879A (he) | 2009-08-02 | 2010-08-02 |
Country Status (12)
Country | Link |
---|---|
US (1) | US8647632B2 (he) |
EP (2) | EP2461829B1 (he) |
JP (3) | JP2013500739A (he) |
KR (1) | KR101623355B1 (he) |
CN (1) | CN102596247B (he) |
AU (1) | AU2010280368B2 (he) |
CA (1) | CA2769001C (he) |
HK (1) | HK1171672A1 (he) |
IL (3) | IL200202A0 (he) |
IN (1) | IN2012DN00879A (he) |
SG (2) | SG10201404735VA (he) |
WO (1) | WO2011016026A2 (he) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014525236A (ja) * | 2011-08-08 | 2014-09-29 | ツー トゥー バイオテック リミテッド | 代謝障害、心障害及び免疫関連障害を治療するための方法における新規なペプチド、それを含む組成物及びそれらの使用 |
EP3089988A4 (en) * | 2014-01-02 | 2017-08-02 | Two To Biotech Ltd. | Novel polypeptides |
CN104262468B (zh) * | 2014-09-28 | 2017-01-18 | 新乡医学院 | 一种葡萄糖转运蛋白抑制多肽及其制备方法、应用 |
EP3265505B1 (en) | 2015-03-05 | 2019-06-19 | Sekisui Specialty Chemicals America, LLC | Pvoh dispersant for vcm polymerization |
KR20240005121A (ko) * | 2015-12-11 | 2024-01-11 | 고쿠리츠다이가쿠호진 고치다이가쿠 | 췌장암 및 췌장관 내 유두상 점액성 종양의 마커 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US5286846A (en) | 1991-06-14 | 1994-02-15 | The Government Of The United States Of America As Represented By The Dept. Of Health And Human Services | Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides |
US6551795B1 (en) * | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
AU2001261513A1 (en) * | 2000-05-15 | 2001-11-26 | Braswell, Glenn A. | Composition and method for increasing testosterone levels |
EP1296706B1 (en) * | 2000-06-19 | 2006-02-22 | The Uab Research Foundation | Osteoclast secreted chemokine and uses thereof |
AU2003900747A0 (en) | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
CA2583230A1 (en) * | 2004-10-05 | 2006-04-20 | Oregon Health And Science University | Compositions and methods for treating disease |
US20080248134A1 (en) * | 2005-05-04 | 2008-10-09 | Auckland Uniservices Limited | Oral compositions, use and combinations of N-[2-(dimethylamino)ethyl]-2,6 dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide and closely related analogues thereof |
EP2097538A4 (en) * | 2006-12-07 | 2011-11-30 | Switchgear Genomics | TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS |
-
2009
- 2009-08-02 IL IL200202A patent/IL200202A0/en unknown
-
2010
- 2010-08-02 WO PCT/IL2010/000621 patent/WO2011016026A2/en active Application Filing
- 2010-08-02 JP JP2012523432A patent/JP2013500739A/ja active Pending
- 2010-08-02 AU AU2010280368A patent/AU2010280368B2/en not_active Ceased
- 2010-08-02 SG SG10201404735VA patent/SG10201404735VA/en unknown
- 2010-08-02 US US13/387,392 patent/US8647632B2/en active Active
- 2010-08-02 SG SG2012005070A patent/SG178097A1/en unknown
- 2010-08-02 EP EP10806144.1A patent/EP2461829B1/en not_active Not-in-force
- 2010-08-02 CA CA2769001A patent/CA2769001C/en not_active Expired - Fee Related
- 2010-08-02 CN CN201080044688.3A patent/CN102596247B/zh not_active Expired - Fee Related
- 2010-08-02 IN IN879DEN2012 patent/IN2012DN00879A/en unknown
- 2010-08-02 KR KR1020127004449A patent/KR101623355B1/ko not_active IP Right Cessation
- 2010-08-02 EP EP15182357.2A patent/EP2985035A1/en not_active Withdrawn
-
2012
- 2012-01-26 IL IL217758A patent/IL217758A/he not_active IP Right Cessation
- 2012-12-05 HK HK12112520.0A patent/HK1171672A1/zh not_active IP Right Cessation
-
2015
- 2015-03-11 JP JP2015047903A patent/JP5833780B2/ja not_active Expired - Fee Related
- 2015-07-23 IL IL240134A patent/IL240134A/he not_active IP Right Cessation
- 2015-08-06 JP JP2015155720A patent/JP2015212302A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2461829A4 (en) | 2013-06-19 |
EP2461829B1 (en) | 2016-01-06 |
IL240134A (he) | 2016-07-31 |
CN102596247A (zh) | 2012-07-18 |
WO2011016026A3 (en) | 2011-05-26 |
EP2461829A2 (en) | 2012-06-13 |
AU2010280368B2 (en) | 2015-07-23 |
CA2769001C (en) | 2016-07-26 |
CN102596247B (zh) | 2014-08-06 |
IL200202A0 (en) | 2010-05-31 |
IL217758A0 (en) | 2012-03-29 |
EP2985035A1 (en) | 2016-02-17 |
IL240134A0 (he) | 2015-09-24 |
KR101623355B1 (ko) | 2016-05-23 |
JP2015212302A (ja) | 2015-11-26 |
SG178097A1 (en) | 2012-03-29 |
WO2011016026A2 (en) | 2011-02-10 |
AU2010280368A1 (en) | 2012-03-15 |
JP5833780B2 (ja) | 2015-12-16 |
KR20120063474A (ko) | 2012-06-15 |
SG10201404735VA (en) | 2014-10-30 |
JP2015157811A (ja) | 2015-09-03 |
HK1171672A1 (zh) | 2013-04-05 |
US8647632B2 (en) | 2014-02-11 |
US20120121602A1 (en) | 2012-05-17 |
JP2013500739A (ja) | 2013-01-10 |
CA2769001A1 (en) | 2011-02-10 |
IL217758A (he) | 2015-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2012000167A1 (en) | Human il-23 antigen binding proteins | |
MX346923B (es) | Genes y proteinas para sintesis de alcanoil-coa. | |
MY159398A (en) | Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide | |
MX2016003943A (es) | Composiciones y formulaciones para la prevencion y reduccion de tumorigenesis, invasion y proliferacion de celulas de cancer y metodos de produccion y uso en el tratamiento del cancer. | |
WO2013048883A3 (en) | Anti-erbb3 antibodies and uses thereof | |
MX2015008446A (es) | Composiciones de proteinas de union multivalentes. | |
IN2012DN01920A (he) | ||
UA111711C2 (uk) | Засіб імунотерапії деяких видів пухлин, у тому числі раку шлунково-кишкового тракту і раку шлунка | |
NZ603271A (en) | Anti-erbb3 antibodies | |
MX2013003681A (es) | Ácidos nucleicos manipulados y métodos de uso de los mismos. | |
MD4548B1 (ro) | Polipeptide care se leagă de CX3CR1 | |
WO2011139714A3 (en) | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase | |
MX2013002379A (es) | Moleculas de union a vegf. | |
WO2011146527A3 (en) | Mammalian genes involved in infection | |
IN2012DN00879A (he) | ||
WO2013177593A3 (en) | Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies | |
WO2013003037A3 (en) | Anti-erbb3 antibodies in combination with paclitaxel for treatment of gynecological cancers | |
MY180183A (en) | Methods and compositions for preventing norleucine misincorporation into proteins | |
WO2014151834A3 (en) | Methods and compositions relating to anti-ccr7 antigen binding proteins | |
WO2012122378A3 (en) | Antibody-like proteins for therapeutic and diagnostic use | |
WO2009146463A3 (en) | Variant hhip1 protein and methods and uses thereof | |
WO2011085134A8 (en) | Methods and compositions for the diagnosis, prognosis and treatment of cancer | |
WO2011005523A3 (en) | Galectin-immunoglobulin chimeric molecules | |
WO2013109190A3 (en) | Cho-gmt recombinant protein expression | |
EP1984013A4 (en) | CST II MODIFICATIONS FOR INCREASED PROTEIN EXPRESSION |